GENinCode (LON:GENI) Stock Price Up 0.5% – Here’s What Happened

GENinCode Plc (LON:GENI) shot up 0.5% on Friday . The company traded as high as GBX 1.10 and last traded at GBX 0.95. Approximately 3,773,302 shares were traded during mid-day trading, a decline of 29% from the average daily volume of 5,290,828 shares. The stock had previously closed at GBX 0.95.

GENinCode Trading Up 0.5%

The company has a debt-to-equity ratio of 117.74, a quick ratio of 15.88 and a current ratio of 0.93. The stock has a market cap of £7.19 million, a P/E ratio of -0.46 and a beta of 0.56. The stock has a 50-day moving average price of GBX 0.87 and a 200-day moving average price of GBX 1.02.

GENinCode (LON:GENI) last posted its quarterly earnings data on Monday, June 8th. The company reported GBX (2.08) earnings per share for the quarter. GENinCode had a negative return on equity of 409.40% and a negative net margin of 185.47%.The company had revenue of GBX 308 million during the quarter. On average, equities research analysts expect that GENinCode Plc will post -7.1299999 EPS for the current year.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.